Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and

Jianyong Liu1, Heather Martin, Meir Shamay

  • 1Johns Hopkins University School of Medicine, Bunting-Blaustein Building CRB308, 1650 Orleans Street, Baltimore, MD 21231, USA.

Journal of Virology
|February 23, 2007
PubMed

Insights

Kaposi's sarcoma-associated herpesvirus LANA protein inactivates nuclear GSK-3 by recruiting ERK1/2 and RSK1. This LANA-mediated GSK-3 inactivation inhibits C/EBP phosphorylation, impairing cell differentiation.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) interacts with glycogen synthase kinase 3 (GSK-3).
  • This interaction leads to beta-catenin stabilization and upregulation of beta-catenin-responsive genes.

Purpose of the Study:

  • To investigate the downstream consequences of the LANA-GSK-3 interaction.
  • To elucidate the mechanism by which LANA affects nuclear GSK-3 activity and its substrates.

Main Methods:

  • Co-immunoprecipitation assays to detect protein interactions.
  • In vitro kinase assays to assess LANA as a substrate.
  • Analysis of GSK-3 substrate phosphorylation in LANA-expressing cells.
  • Modeling differentiation in 3T3L1 adipogenesis system.

Main Results:

  • Nuclear GSK-3 bound to LANA is enriched in its inactive, serine 9-phosphorylated form.
  • LANA recruits extracellular signal-regulated kinases 1 and 2 (ERK1/2) and ribosomal S6 kinase 1 (RSK1) for GSK-3 inactivation.
  • LANA expression impairs the phosphorylation of GSK-3 substrates C/EBPbeta and C/EBPalpha.
  • LANA-expressing 3T3L1 cells show impaired adipogenesis and delayed/reduced induction of C/EBPbeta targets.

Conclusions:

  • LANA inactivates nuclear GSK-3 through recruitment of ERK1/2 and RSK1.
  • This inactivation modifies the function of GSK-3 substrates, including C/EBPs.
  • LANA-mediated inhibition of C/EBP phosphorylation results in impaired cell differentiation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...